Corient Private Wealth
UPB

Corient Private Wealth’s Upstream Bio Inc UPB Stock Holding History

Corient Private Wealth’s Portfolio UPB Stock Details UPB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$109K Buy
+12,157
New +$219K ﹤0.01% 2671

Other funds holding UPB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Corient Private Wealth's UPB Position: Q1 2026 in Review

Corient Private Wealth opened a new position in Upstream Bio Inc (UPB) in Q1 2026: 12,157 shares worth $109K. The stake represents ﹤0.01% of the portfolio and ranks #2671 among its holdings.

140 funds tracked by Wall St. Rank hold UPB as of Q1 2026.

  • Corient Private Wealth held 12,157 shares of Upstream Bio Inc worth $109K as of Q1 2026.
  • Upstream Bio Inc was a new Corient Private Wealth position in Q1 2026.
  • Upstream Bio Inc made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #2671 holding.
  • 140 funds tracked by Wall St. Rank held Upstream Bio Inc as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.